P10 - Use of microbial biotransformation to produce scalable quantities of a glucuronidated metabolite of the clinical-stage soluble guanylate cyclase inhibitor praliciguat. (2020) - Shanu-Wilson, Julia; Steele, Jonathan; Phipps, Richard; Manohar, Ravi; Karunakaran, Deepa; Borowik, Alicja; Scheffler, Frank; Evans, Liam; Carvalho, Andrew; Banijamali, Ali